Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.

Categoría Estudio primario
RevistaNeurology
Año 1996
Cargando información sobre las referencias
Two double-blinded, placebo-controlled clinical trials of riluzole have now been carried out in more than 1,100 patients with ALS. The results of both studies show a modest benefit in prolonging survival that is statistically significant. These results led to the availability of this drug by the Food and Drug Administration for use in the United States beginning in early 1996. This is the first drug that has been available for ALS. It begins a new era in both basic and clinical research in an attempt to find a cure for this disease.
Epistemonikos ID: a24db242244cf8b2d7feeea144c0a6eb41578fe0
First added on: May 14, 2022